COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Bioactive molecules of grape
- Investigating bacterial gastroenteritis prevalence in the population of Tizi-Ouzou city under the context of social distancing and barrier measures
- Pica in sickle cell disease: nutritional management and implications
- The role of nutrition in strengthening immune system against newly emerging viral diseases: case of SARS-CoV-2
- Nutritional evaluation, oxidative indexes, and functional properties of Irish potatoes, eggs, and red kidney beans based complementary food
- Neurotoxic and neuromotor effects of cyanate, an oxidative byproduct of cyanide from linamarin in cassava: A systematic review
- Study pattern of nutritional recovery in edematous and non-edematous malnourished children after a short hospital stay of nutrition rehabilitation
- Anti-inflammatory activity of doum palm fruit extract used in the management of benign prostatic hyperplasia
- Immune-stimulating and antioxidant properties of a traditional Algerian plant combination: Date fruit (Phoenix dactylifera) and Fenugreek seeds (Trigonella foenum-graecum)
- Prevalence of Peptic Ulcer Disease and Dietary Pattern among Students of a Private University in Nigeria
You may also start an advanced similarity search for this article.
NAJFNR is licensed under